Both in Pharmaceuticals
Dyne Therapeutics vs Precigen
Over the past year DYN returned +31.0% and PGEN returned +121.8%; their daily moves had a correlation of 0.28.
DYN +31.0% PGEN +121.8%Growth of $1, one year, split-adjusted
| Metric | DYN | PGEN |
|---|---|---|
| Price | $16.21 | $8.05 |
| Market cap | $3.03B | $2.88B |
| Today | −0.80% | +3.07% |
| 1 month | −35.3% | +15.8% |
| 6 months | −5.1% | +147.7% |
| Year to date | −17.1% | +92.6% |
| 1 year | +23.3% | +129.3% |
| Revenue growth (YoY) | — | +6322.7% |
| Gross margin | — | 94.9% |
| Net margin | — | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 33.6× |
| Net cash | $685.0M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 54.5% |
| Short % of float | 13.4% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).